Summary
Merck & Co., Inc. (MRK) filed an 8-K on May 1, 2018, to report its financial results for the first quarter of 2018, which concluded on April 30, 2018. The filing primarily incorporates by reference a press release (Exhibit 99.1) detailing the company's performance and supplemental information (Exhibit 99.2) not found in the press release. This report provides investors with key financial data and operational updates for the initial quarter of the fiscal year. While the 8-K itself does not contain the detailed financial figures, it directs investors to the accompanying exhibits for a comprehensive understanding of Merck's Q1 2018 earnings. Investors should review Exhibits 99.1 and 99.2 to assess the company's revenue, profitability, and any significant business developments announced during the period. The filing also notes Merck's status as an emerging growth company but does not elect to use the extended transition period for new accounting standards.
Key Highlights
- 1Merck & Co., Inc. (MRK) filed an 8-K on May 1, 2018, to announce Q1 2018 earnings.
- 2The primary information is contained within the referenced press release (Exhibit 99.1).
- 3Supplemental financial and operational data is provided in Exhibit 99.2.
- 4The filing covers the financial performance and condition for the quarter ending April 30, 2018.
- 5Merck is identified as an emerging growth company.
- 6The company has opted not to use the extended transition period for new accounting standards.